Other formats:
BibTeX
LaTeX
RIS
@article{1351896, author = {Ustohal, Libor and Mayerová, Michaela and Valková, Barbora and Sedláková, Hana and Kašpárek, Tomáš}, article_location = {PHILADELPHIA}, article_number = {2}, doi = {http://dx.doi.org/10.1097/JCP.0000000000000460}, keywords = {ACUTE-PANCREATITIS}, language = {eng}, issn = {0271-0749}, journal = {JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY}, title = {Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment}, url = {http://journals.lww.com/psychopharmacology/Citation/2016/04000/Asymptomatic_Elevation_of_Amylase_and_Lipase_After.18.aspx}, volume = {36}, year = {2016} }
TY - JOUR ID - 1351896 AU - Ustohal, Libor - Mayerová, Michaela - Valková, Barbora - Sedláková, Hana - Kašpárek, Tomáš PY - 2016 TI - Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment JF - JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY VL - 36 IS - 2 SP - 181-183 EP - 181-183 PB - LIPPINCOTT WILLIAMS & WILKINS SN - 02710749 KW - ACUTE-PANCREATITIS UR - http://journals.lww.com/psychopharmacology/Citation/2016/04000/Asymptomatic_Elevation_of_Amylase_and_Lipase_After.18.aspx L2 - http://journals.lww.com/psychopharmacology/Citation/2016/04000/Asymptomatic_Elevation_of_Amylase_and_Lipase_After.18.aspx N2 - Olanzapine, an atypical antipsychotic,has been considered one of the most efficient antipsychotic drugs, and it is the most frequently prescribed. It is categorized as a multiacting receptor targeted antipsychotic. The most significant adverse effects of olanzapine are metabolic: acute pancreatitis is one of the most serious adverse effects; fortunately, it does not occur very often. Koller et al1 found 51 cases,and at least 13 cases have been described more precisely. We present a case study of a young female patient with a very fast and high increase of amylase and lipase, who remained asymptomatic, immediately after olanzapine treatment. ER -
USTOHAL, Libor, Michaela MAYEROVÁ, Barbora VALKOVÁ, Hana SEDLÁKOVÁ and Tomáš KAŠPÁREK. Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment. \textit{JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY}. PHILADELPHIA: LIPPINCOTT WILLIAMS \&{} WILKINS, 2016, vol.~36, No~2, p.~181-183. ISSN~0271-0749. Available from: https://dx.doi.org/10.1097/JCP.0000000000000460.
|